Dr. Rogal is an implementation scientist and health services researcher focused on improving the equity and quality of care for people with liver diseases and other complex, chronic conditions.
- BS, Yale University, 2001
- MD, Yale University School of Medicine, 2006
- MPH, Yale University School of Epidemiology and Public Health, 2006
- Residency, Internal Medicine, Brigham and Women's Hospital, 2009
- Fellowship, Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, 2013
- Fellowship, Transplant Hepatology, University of Pittsburgh, 2014
Education & Training
Rogal, S.S., Landsittel, D., Surman, O., Chung, R., Rutherford, A. Pretransplant Depression, Antidepressant Use, and Outcomes of Orthotopic Liver Transplantation. Liver Transplantation. 2011; 17(3): 251-60.
Rogal, S.S., Pinsky, P.F., Schoen, R.E. Relationship between Detection of Adenomas by Flexible Sigmoidoscopy and Interval Distal Colorectal Cancer. Clinical Gastroenterology and Hepatology. 2013; 11(1): 73-8.
Rogal, S.S., Dew, M.A., Fontes, P., DiMartini, A.F. Early Treatment of Depressive Symptoms and Long-Term Survival after Liver Transplantation. American Journal of Transplantation. 2013; 13(4): 928-35.
Rogal, S.S., Winger, D., Bielefeldt, K., Szigethy, E. Pain and Opioid Use in Chronic Liver Disease. Digestive Diseases and Sciences. 2013; 58(10): 2976-85.
Rogal, S.S., Winger, D., Bielefeldt, K., Rollman, B.F., Szigethy, E. Healthcare Utilization in Chronic Liver Disease: the Role of Pain and Opioid Use. Liver International. 2013; 33(10): 1497-503.
Rogal, S.S., Wasan, A., Bielefeldt, K., Lotrich, F., Zickmund, S., Szigethy, E., DiMartini, A. Inflammation, Psychiatric Symptoms, and Opioid Use are Associated with Pain and Disability in Patients with Cirrhosis. Clinical Gastroenterology and Hepatology. 2015; 13(5): 1009-16.
Butt, A.A., Yan, P., Bonilla, H., Abou-Samra, A.B., Shaikh, O.S., Simon, T.G., Chung, R.T., Rogal, S.S. Effect of the Addition of Statins to Antiviral Therapy in HCV Infected Persons: Results of ERCHIVES. Hepatology. 2015; 62(2): 365-74.
Rogal, S.S., Yan, P., Rimland, D., Lo Re, V., Al-Rowais, H., Fried, L., Butt, A.A. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion. 2015
Chidi, A., Rogal, S.S., Bryce, C.L., Fine, M.J., Good, C.B., Myaskovsky, L., Rustgi, V., Tsung, A., Smith, K.J. Cost-Effectiveness of New Antiviral Regimens for Treatment-Naive US Veterans with Hepatitis C. Hepatology. 2016; 63(2): 428-36.
Rogal, S.S., Arnold, R.A., Chapko, M.K., Hanusa, B.V., Youk, A., Switzer, G.E., Sevick, M.A., Bayliss, N.K., Zook, C.L., Chidi, A., Obrosky, D.S., Zickmund, S.L. The Patient-Provider Relationship is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study. PlosOne. 2016
